Samsrita Labs made ₹0 revenue last year. Its auditor flagged a ₹2.09 cr write-off.
Zero revenue, an ₹8.69 cr standalone loss, and an auditor flag on a bad-debt write-off define a year with no commercial activity.
— 1 earlier story on Samsrita Labs Ltd. →What's new
- Samsrita Labs reported zero revenue and a standalone net loss of ₹8.69 cr for FY26.
- Auditors flagged a ₹2.09 cr write-off of irrecoverable receivables from Mangal Savitri Bizcon.
- Accumulated losses pushed reserves to negative ₹11.41 cr, even after a ₹3.39 cr equity raise.
Why this matters
A company with zero revenue and negative reserves is not in a turnaround. It's in a search for a business. The auditor flag on the write-off is a governance issue, not just a financial one. The pivot to pet and home products is a plan without evidence.
What we're watching
- Whether the company reports any revenue from the new pet and home-care strategy in Q1 FY27.
- If another equity raise is needed to cover the cash burn.
- The auditor's going-concern opinion next cycle.
The full read
Samsrita Labs is a healthcare company that made ₹0 in revenue last year. It lost ₹8.69 crore as a standalone entity, pushing accumulated losses into negative territory at ₹11.41 crore. The auditors flagged the ₹2.09 crore write-off of receivables from Mangal Savitri Bizcon, a governance mark that won't age well. Cash sits at ₹1.63 crore, but only because investors injected ₹3.39 crore in new equity. The company now plans to pivot to pet and home-care products. A nano-cap burning cash it just raised, with no revenue and negative reserves, isn't positioning for growth. It's searching for a business model.
Questions answered
- How does a company with zero revenue end the year with positive cash?
- Samsrita raised ₹3.39 crore in fresh equity during the year, bringing its cash balance to ₹1.63 crore. The money came in as an investment; none came in as revenue.
- What did the auditors flag, and why?
- The auditors issued an 'emphasis of matter' on the ₹2.09 crore write-off of trade receivables from Mangal Savitri Bizcon, which the company deemed irrecoverable. It's a governance mark on asset quality.
- What is the scale of these losses versus the company's size?
- The standalone loss of ₹8.69 crore is about 26% of the company's ₹34 crore market capitalization. The negative reserves now exceed the cash position.
- What is the company's business plan now?
- After a year of zero operations in healthcare, it plans to expand into pet and home-need products and services in FY27. No further detail is given on the timeline or investment required.
Story so far
All notes on SAMSRITA →- 29 May 2026 · 6:39 PM IST Samsrita Labs made ₹0 revenue last year. Its auditor flagged a ₹2.09 cr write-off.
- 1d ago Samsrita Labs reports zero revenue, writes off ₹2.09 cr receivables